1. Home
  2. SAMG vs KRRO Comparison

SAMG vs KRRO Comparison

Compare SAMG & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • KRRO
  • Stock Information
  • Founded
  • SAMG 2002
  • KRRO 2014
  • Country
  • SAMG United States
  • KRRO United States
  • Employees
  • SAMG N/A
  • KRRO N/A
  • Industry
  • SAMG Investment Managers
  • KRRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAMG Finance
  • KRRO Health Care
  • Exchange
  • SAMG Nasdaq
  • KRRO Nasdaq
  • Market Cap
  • SAMG 151.1M
  • KRRO 147.4M
  • IPO Year
  • SAMG 2013
  • KRRO 2019
  • Fundamental
  • Price
  • SAMG $16.78
  • KRRO $20.04
  • Analyst Decision
  • SAMG
  • KRRO Strong Buy
  • Analyst Count
  • SAMG 0
  • KRRO 7
  • Target Price
  • SAMG N/A
  • KRRO $96.71
  • AVG Volume (30 Days)
  • SAMG 24.8K
  • KRRO 132.3K
  • Earning Date
  • SAMG 07-31-2025
  • KRRO 08-12-2025
  • Dividend Yield
  • SAMG 5.24%
  • KRRO N/A
  • EPS Growth
  • SAMG N/A
  • KRRO N/A
  • EPS
  • SAMG 0.87
  • KRRO N/A
  • Revenue
  • SAMG $124,451,000.00
  • KRRO $6,281,000.00
  • Revenue This Year
  • SAMG $3.93
  • KRRO $65.08
  • Revenue Next Year
  • SAMG $5.56
  • KRRO N/A
  • P/E Ratio
  • SAMG $19.30
  • KRRO N/A
  • Revenue Growth
  • SAMG 4.13
  • KRRO N/A
  • 52 Week Low
  • SAMG $13.54
  • KRRO $10.29
  • 52 Week High
  • SAMG $19.20
  • KRRO $98.00
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 57.70
  • KRRO 64.81
  • Support Level
  • SAMG $15.99
  • KRRO $18.52
  • Resistance Level
  • SAMG $16.40
  • KRRO $21.08
  • Average True Range (ATR)
  • SAMG 0.37
  • KRRO 1.67
  • MACD
  • SAMG -0.02
  • KRRO 0.29
  • Stochastic Oscillator
  • SAMG 79.00
  • KRRO 78.80

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: